Pages

Tuesday, 16 April 2019

Johnson & Johnson posts strong revenue, profit in 1Q


Johnson & Johnson posts strong revenue, profit in 1Q



Johnson & Johnson is topping profit and revenue expectations for the first quarter partially on strong sales of its psoriasis treatment, Stelara.

No comments:

Post a Comment